drugset / Trial / NCT00129220
Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to confirm the efficacy of olanzapine in the treatment of manic or mixed symptoms associated with bipolar I disorder.
Timeline
- Start
- 2005-07
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Haloperidol | Other / unclassified | 2.5 mg | Oral |
| Comparator | Haloperidol | Other / unclassified | 10 mg | Oral |
| Subject | Olanzapine | Small molecule | 5 mg | Oral |
| Subject | Olanzapine | Small molecule | 20 mg | Oral |